Eric Bjerkholt
CHIEF FINANCIAL OFFICER; Director · 12 filings · Latest: Sep 11, 2026
CERUS CORP
Metagenomi Therapeutics, Inc.
Mirum Pharmaceuticals, Inc.
Surrozen, Inc./DE
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MIRM | ERIC BJERKHOLT | — | Sep 14, 2026 | Proposed Sale | $98.37 | 9,943 | $978.1K | — | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Sep 14, 2026 | Sale | $98.37 | 9,943 | $978.1K | 44,745 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Sep 11, 2026 | Option Exercise | — | 18,333 | — | 54,688 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Aug 11, 2026 | Sale | $99.90 | 6,001 | $599.5K | 36,355 | |
MIRM | ERIC BJERKHOLT | — | Aug 11, 2026 | Proposed Sale | $99.90 | 6,001 | $599.5K | — | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Jul 6, 2026 | Sale | $122.25 | 5,000 | $611.3K | 42,181 | |
MIRM | ERIC BJERKHOLT | — | Jul 6, 2026 | Proposed Sale | $122.25 | 5,000 | $611.3K | — | |
CERS | Eric Bjerkholt | Director | Jun 9, 2026 | Sale | $2.60 | 20,454 | $53.2K | 261,679 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Jun 9, 2026 | Option Exercise | $26.49 | 2,393 | $63.4K | 47,181 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Jun 8, 2026 | Sale | $93.82 | 5,000 | $469.1K | 44,788 | |
CERS | ERIC BJERKHOLT | — | Jun 9, 2026 | Proposed Sale | $2.60 | 20,454 | $53.2K | — | |
MIRM | ERIC BJERKHOLT | — | Jun 8, 2026 | Proposed Sale | $93.81 | 5,000 | $469.1K | — | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Mar 16, 2026 | Sale | $91.98 | 7,287 | $670.2K | 49,788 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Mar 15, 2026 | Option Exercise | — | 13,334 | — | 57,075 | |
MIRM | ERIC BJERKHOLT | — | Mar 16, 2026 | Proposed Sale | $92.64 | 7,287 | $675.1K | — | |
MIRM | ERIC BJERKHOLT | — | Jan 26, 2026 | Proposed Sale | $96.92 | 1,053 | $102.1K | — | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Jan 26, 2026 | Sale | $96.19 | 1,053 | $101.3K | 43,741 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Jan 23, 2026 | Option Exercise | — | 2,667 | — | 44,794 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Jan 22, 2026 | Sale | $93.33 | 1,421 | $132.6K | 42,127 | |
MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Jan 21, 2026 | Option Exercise | — | 3,334 | — | 43,548 |
Page 1 of 2
Next →